Acar Çevik, U. Et Al. 2025. Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies. ACS OMEGA , vol.10 , 1-13.

Acar Çevik, U., Çelik, İ., Görgülü, Ş., Şahin İnan, Z. D., Bostancı, H. E., Karayel, A., ... Özkay, Y.(2025). Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies. ACS OMEGA , vol.10, 1-13.

Acar Çevik, ULVİYE Et Al. "Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies," ACS OMEGA , vol.10, 1-13, 2025

Acar Çevik, ULVİYE A. Et Al. "Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies." ACS OMEGA , vol.10, pp.1-13, 2025

Acar Çevik, U. Et Al. (2025) . "Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies." ACS OMEGA , vol.10, pp.1-13.

@article{article, author={ULVİYE ACAR ÇEVİK Et Al. }, title={Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies}, journal={ACS OMEGA}, year=2025, pages={1-13} }